iBio Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Cover
- Document And Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Stockholders' Equity (Wainwright Underwriting and Vesting of RSUs) (Details)

v3.23.3

Stockholders' Equity (Wainwright Underwriting and Vesting of RSUs) (Details)		12 Months Ended
	Dec. 06, 2022 USD ($) shares	Jun. 30, 2023 shares	Jun. 30, 2022 shares	Aug. 04, 2023 shares
Restricted Stock Units [Member]
Shares vested		217,553	8,854
Series A warrants
Warrants to purchase shares of Common Stock				3,475,916
Series B warrants
Warrants to purchase shares of Common Stock				2,058,000
H.C. Wainwright & Co., LLC [Member]
Warrants to purchase shares of Common Stock	201,923
Percentage of underwriting discount	7.00%
Number of days granted to purchase additional shares	30
Additional shares issued	504,807
Warrants to purchase additional shares	1,009,614
Percentage of number of shares	6.00%
Net proceeds \| $	$ 2,864,000
H.C. Wainwright & Co., LLC [Member] \| Series A warrants
Warrants to purchase shares of Common Stock	504,807
H.C. Wainwright & Co., LLC [Member] \| Series B warrants
Warrants to purchase shares of Common Stock	504,807
H.C. Wainwright & Co., LLC [Member] \| Over-Allotment Option [Member]
Shares issued	1,530,769
H.C. Wainwright & Co., LLC [Member] \| Over-Allotment Option [Member] \| Pre Funded Warrants [Member]
Warrants to purchase shares of Common Stock	1,834,616
H.C. Wainwright & Co., LLC [Member] \| Over-Allotment Option [Member] \| Series A warrants
Warrants to purchase shares of Common Stock	3,365,385
H.C. Wainwright & Co., LLC [Member] \| Over-Allotment Option [Member] \| Series B warrants
Warrants to purchase shares of Common Stock	3,365,385

- Definition

Number of common warrants to purchase additional shares.

+ References

No definition available.

+ Details

Name:	ibio_CommonWarrantsToPurchaseAdditionalShares
Namespace Prefix:	ibio_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of additional shares issued.

+ References

No definition available.

+ Details

Name:	ibio_NumberOfAdditionalSharesIssued
Namespace Prefix:	ibio_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of days option to purchase additional shares.

+ References

No definition available.

+ Details

Name:	ibio_NumberOfDaysOptionToPurchaseAdditionalShares
Namespace Prefix:	ibio_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Percentage of aggregate number of shares of common stock.

+ References

No definition available.

+ Details

Name:	ibio_PercentageOfAggregateNumberOfSharesOfCommonStock
Namespace Prefix:	ibio_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of underwriting discount paid on gross proceeds of offering.

+ References

No definition available.

+ Details

Name:	ibio_PercentageOfUnderwritingDiscountPaidOnGrossProceedsOfOffering
Namespace Prefix:	ibio_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 14
-Subparagraph (a)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-14

+ Details

Name:	us-gaap_ProceedsFromIssuanceOfWarrants
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(02)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of new stock issued during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-SubTopic 10
-Topic 505
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481004/946-505-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(4)(b))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(i)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=ibio_SeriesWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=ibio_SeriesBWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=ibio_H.c.WainwrightCo.LlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=ibio_PreFundedWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: